Experts predict that the Alpha Mannosidosis market is on the brink of significant transformation, driven by emerging trends that signal growth and innovation. The market is set to witness a robust expansion, increasing from a valuation of $15.02 million in 2024 to an impressive $33.97 million by 2035, as the industry adapts to the evolving landscape of healthcare. The anticipated CAGR of 7.70%...